Ritter Daniher Financial Advisory LLC Moderna, Inc. Transaction History

Ritter Daniher Financial Advisory LLC

  • $339 Million
  • Q3 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$63.64 - $125.14 $0 - $0
0 New
0 $0
Q2 2024

Aug 12, 2024
BUY
$101.21 - $166.61 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$85.37 - $115.44 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$69.51 - $104.43 $0 - $0
0 New
0 $0
Q3 2023

Nov 09, 2023
BUY
$96.41 - $126.61 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
SELL
$118.5 - $160.53 $118 - $160
-1 Closed
0 $0
Q4 2022

Feb 10, 2023
BUY
$118.38 - $210.04 $118 - $210
1 New
1 $0

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ritter Daniher Financial Advisory LLC Portfolio

Follow Ritter Daniher Financial Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritter Daniher Financial Advisory LLC , based on Form 13F filings with the SEC.

News

Stay updated on Ritter Daniher Financial Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email